Shattuck Labs, Inc. Increase Decrease In Operating Lease Liability
Shattuck Labs, Inc. (STTK) reported Increase Decrease In Operating Lease Liability of $216.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-11
- Shattuck Labs, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was $441.00K.
- Shattuck Labs, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$225.00K.
- Shattuck Labs, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$278.00K.
- Shattuck Labs, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$154.00K.
- Shattuck Labs, Inc. increase decrease in operating lease liability for fiscal 2025 was -$922.00K.
- Shattuck Labs, Inc. increase decrease in operating lease liability for fiscal 2024 was -$900.00K.
- Shattuck Labs, Inc. increase decrease in operating lease liability for fiscal 2023 was -$796.00K.
- Shattuck Labs, Inc. increase decrease in operating lease liability for fiscal 2022 was -$702.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $441.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $216.00K 10-Q · filed 2026-08-11 | -$62.00K derived: sum of 3 quarters · filed 2026-08-11 | -$216.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$225.00K 10-Q · filed 2026-05-07 | -$503.00K derived: sum of 2 quarters · filed 2026-05-07 | -$657.00K derived: sum of 3 quarters · filed 2026-05-07 | -$907.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$278.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$432.00K derived: sum of 2 quarters · filed 2026-03-05 | -$682.00K derived: sum of 3 quarters · filed 2026-08-11 | -$922.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | -$154.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$404.00K derived: sum of 2 quarters · filed 2026-08-11 | -$644.00K 10-Q · filed 2025-11-06 | -$880.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$250.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$490.00K 10-Q · filed 2026-08-11 | -$726.00K derived: sum of 3 quarters · filed 2026-08-11 | -$956.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$240.00K 10-Q · filed 2026-05-07 | -$476.00K derived: sum of 2 quarters · filed 2026-05-07 | -$706.00K derived: sum of 3 quarters · filed 2026-05-07 | -$927.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$236.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$466.00K derived: sum of 2 quarters · filed 2026-03-05 | -$687.00K derived: sum of 3 quarters · filed 2026-03-05 | -$900.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | -$230.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$451.00K derived: sum of 2 quarters · filed 2025-11-06 | -$664.00K 10-Q · filed 2025-11-06 | -$873.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$221.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$434.00K 10-Q · filed 2025-08-14 | -$643.00K derived: sum of 3 quarters · filed 2025-08-14 | -$846.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$213.00K 10-Q · filed 2025-05-01 | -$422.00K derived: sum of 2 quarters · filed 2025-05-01 | -$625.00K derived: sum of 3 quarters · filed 2025-05-01 | -$821.00K derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | -$209.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$412.00K derived: sum of 2 quarters · filed 2025-03-27 | -$608.00K derived: sum of 3 quarters · filed 2025-03-27 | -$796.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | -$203.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$399.00K derived: sum of 2 quarters · filed 2024-11-14 | -$587.00K 10-Q · filed 2024-11-14 | -$772.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$196.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$384.00K 10-Q · filed 2024-08-01 | -$569.00K derived: sum of 3 quarters · filed 2024-08-01 | -$749.00K derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | -$188.00K 10-Q · filed 2024-05-02 | -$373.00K derived: sum of 2 quarters · filed 2024-05-02 | -$553.00K derived: sum of 3 quarters · filed 2024-05-02 | -$725.00K derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | -$185.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$365.00K derived: sum of 2 quarters · filed 2024-02-29 | -$537.00K derived: sum of 3 quarters · filed 2024-02-29 | -$702.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | -$180.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$352.00K derived: sum of 2 quarters · filed 2023-11-09 | -$517.00K 10-Q · filed 2023-11-09 | -$517.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$172.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$337.00K 10-Q · filed 2023-08-10 | -$337.00K derived: sum of 3 quarters · filed 2023-08-10 | -$337.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$165.00K 10-Q · filed 2023-05-09 | -$165.00K derived: sum of 2 quarters · filed 2023-05-09 | -$165.00K derived: sum of 3 quarters · filed 2023-05-09 | -$165.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | $0.00 10-K · filed 2023-02-23 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |